Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. (Record no. 22620611)

MARC details
000 -LEADER
fixed length control field 01687 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516142555.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201305s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1534-4436
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.anai.2013.02.007
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Riedl, Marc A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20130523
245 00 - TITLE STATEMENT
Title Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Date of publication, distribution, etc. Apr 2013
300 ## - PHYSICAL DESCRIPTION
Extent 295-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angioedemas, Hereditary
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Complement C1 Inhibitor Protein
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element North America
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Levy, Robyn J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Suez, Daniel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lockey, Richard F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Baker, James W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Relan, Anurag
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zuraw, Bruce L
773 0# - HOST ITEM ENTRY
Title Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Related parts vol. 110
-- no. 4
-- p. 295-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.anai.2013.02.007">https://doi.org/10.1016/j.anai.2013.02.007</a>
Public note Available from publisher's website

No items available.